Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer

NCT06039631 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Larynx Cancer
Hypopharyngeal Cancer

Interventions

PROCEDURE: Surgery
RADIATION: Radiation
DRUG: Toripalimab

Sponsor

Fudan University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]